Paroxysmal nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia characterized by the presence of abnormal subpopulations of blood cells that are deficient in surface expression of glycosylphosphatidylinositol (GPI)-anchored proteins. Recent studies showed that the gene termed PIG-A, which participates in the first step of GPIanchor biosynthesis, is mutated in the abnormal blood cells from patients with PNH. In this study the genomic PIG-A gene was cloned and characterized to obtain nucleotide sequence information for analyzing somatic mutations of PIG-A in patients with PNH. The PIG-A gene is at least 17 kb long AROXYSMAL nocturnal hemoglobinuria (PNH) is an acquired hemolytic anemia."3 In patients with PNH, subpopulations of various blood cell types are deficient in surface expressions of glycosylphosphatidylinositol (GP1)-anchored and have a defect in the first step of GPIanchor biosynthesis!-6 Two complement regulatory proteins, decay-accelerating factor (DAF) and CD59, are GPI-anchored proteins and they protect host cells from the action of complement.'^* In particular, protection of red blood cells (RBCs) is mainly due to these proteins, especially CDS9.9 Because DAF-and CD59-deficient RBCs are susceptible to complement-mediated membrane attack, they are hemolyzed when intravascular complement activation is elevated by an increase of complement-activating substances, such as immune-complex formation during infection or by accelerated spontaneous activation during sleep."
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At least three genes are necessary for the first step of GPIanchor biosynthesis because there are three complementation groups (classes A, C, and H) of GPI-anchor-deficient mutants that do not synthesize the first intermediate.".'2 We recently cloned one of these genes, termed PIG-A (phosphatidylinositolglycan-class e>" and showed that PIG-A is the gene responsible for GPI-anchor deficiency in PNH.I4 More recent analyses showed that PIG-A is responsible for PNH in all patients examined thus
We mapped PIG-A to Xp22.1 .l4 Because the X-chromosomal gene is haploid in somatic cells, this location of PIG-A should account for the phenotypic expression of the somatic mutation. This also explains why, among all of the genes necessary for GPIanchor synthesis, PIG-A is responsible for PNH in all patients.
In the present investigation, we cloned and characterized the genomic PIG-A gene. We sequenced the exon-intron boundaries and S83 bp of the S' flanking region. From these nucleotide sequences and the previously determined sequence of PIG-A cDNA, we designed pairs of oligonucleotide primers for polymerase chain reaction (PCR) amplification of various regions of the PIG-A gene. The information obtained should be useful for analysis of somatic mutations of PIG-A in patients with PNH.
MATERIALS AND METHODS
Isolation and characterization of the human PIG-A gene. Two human genomic libraries were screened to isolate the human PIG-A gene. One was a human B-lymphoblastoid cell library in the phage vector EMBL3, which was constructed using partially Sau3 AIdigested DNA of the SS-2' cell line,I4 a wild-type cell line established from a patient with PNH. The other was a human X-chromo- Filters bearing phage plaques were prehybridized at 42°C for 3 hours in 25 mmoVL potassium phosphate buffer (pH 7.4) containing 5X SSC, 5 x Denhardt's solution, 50 p g h L salmon sperm DNA, and 50% formamide, and then hybridized overnight at 42°C with the heat-denatured probe in the same buffer supplemented with 10% dextran sulfate. The filters were subsequently washed with 2X SSC containing 0.1% sodium dodecyl sulfate at 42°C. After two additional rounds of screening, we obtained one positive phage clone (clone 1). We obtained clone 2 by screening the X-chromosomal library under similar conditions using a 2.3-kb Spe VEcoRI fragment derived from the 5' portion of clone 1 as a probe.
Sizes of inserts were determined by agarose gel electrophoresis after digestion of phage DNA with Sal I. Then, the restriction enzyme map was determined with EcoRI, Xba I, and Spe I . Fragments containing an exon(s) were identified by Southern blot analysis using Determination of the 5'-terminal cDNA sequence. The 5'-end of human PIG-A cDNA was extended and amplified in a system for rapid amplification of 5'-cDNA ends (5' RACE) (GIBCO BRL, Gaithersburg, MD)." An internal antisense primer (primer l), 5'-GATTCTC'ITTGGTCCCTCTCCTC-3' (nucleotides 892 to 869), was used for reverse transcription of total RNA isolated from peripheral human polymorphonuclear leukocytes. Oligo dC nucleotides were added to the synthesized cDNA strand using a terminal transferase. Amplification by PCR was performed using an adaptor-GGG-IIGGGIIGGGIIG primer (the anchor primer), 5'-CUACUACUAand a nested antisense internal primer (primer 2), 5"TTCAGTGCT-GCTC'ITAGTACAG-3' (nucleotides 682 to 659). Instead of the anchor primer, an internal primer (primer 3), 5'-GGTTGCTCTAAG-AACTGATGTC-3' (nucleotides 50 to 71), was used to confirm correct reverse transcription. The amplified products were analyzed by electrophoresis in 2% agarose gel. These products were then subcloned into pBS and the nucleotide sequences of both strands were determined by the dideoxy termination method with a Taq dye primer cycle sequencing kit and a Model 370A DNA sequencer (Applied Biosystems, Foster City, CA).
Construction of deletion mutants of the promoter-regulatory region. A pBS bearing the 0.65-kb EcoRYNco I fragment derived from clone 2 of genomic PIG-A that contained a 0.6-kb region upstream of exon 1 was digested with Pvu I and blunt-ended by Klenow enzyme. This linearized plasmid was purified by agarose gel electrophoresis and digested with HindIII, generating an 800-bp blunt-endIfindII1 fragment containing the 5' flanking region. The 800-bp fragment was ligated into an HindIII-and Sma I-digested luciferase reporter plasmid (PGV-C) (Toyo Ink, Tokyo, Japan). Deletion mutants of this plasmid containing the PIG-A-promoter were generated with exonuclease I11 (Toyobo, Osaka, Japan) and mung bean nuclease (Toyobo).'' Assay of the promoter-regulatory region using a luciferase reporter gene.
The human B-lymphoblastoid cell line JY5I9 was grown in Dulbecco's modified Eagle's medium with 10% fetal calf serum. Samples of IO7 cells of JY5 in 0.8 mL of transfection buffer containing 20 mmoVL HEPES (pH 7.05), 137 mmoVL NaCI, 5 mmoVL KCI, 0.7 mmoVL Na,HPO,, and 6 mmoVL dextrose" were mixed with 20 pg of each deletion mutant of the PIG-A-promoterluciferase construct in electroporation chambers (Shimadzu CO, Kyoto, Japan). Electroporation was performed at 960 pF and 250 V in CUAGGCCACGCGTCGACTAGTACGGGIIGGGIIGGGIIG-3', an electroporator (Gene Pulser; Bio-Rad Laboratories, Hercules, CA). After a 48-hour culture in the medium, cells were washed twice with phosphate-buffered saline", lysed in a solution consisting of 25 mmol/L Tris-phosphate (pH 7.8), 2 mmoVL dithiothreitol, 2 mmoVL 1,2-diaminocyclohexane-N,N,N',N'-tetraacetic acid, 10% glycerol, and 1% Triton X-100 and then centrifuged. Luciferase activity in the Supernatants was then measured according to the manufacturer's protocol.*' Results are expressed as means in arbitrary units ?SD.
RESULTS AND DISCUSSION
Cloning and characterization of the exon-intron organization of the PIG-A gene. We screened a human total genomic DNA library with a PIG-A cDNA probe and obtained clone 1 (Fig 1) . Because this clone did not contain the 5'-end of the previously cloned cDNA, we screened an Xchromosomal DNA library using the 5"portion of the clone 1 as a probe and obtained clone 2 (Fig 1) . These clones were analyzed by restriction mapping. Restriction fragments containing an exon(s) were identified by Southern blot analysis with PIG-A cDNA probes and sequenced. Comparisons of these sequences with that of cDNA identified six exons (Fig l) . The gene spans approximately 17 kbp. Exon 1 contains 5' untranslated region, and exon 2 the rest of the 5' untranslated region and about half the coding region. The coding region (1,452 bp) extends to the 5' portion of exon 6. The 3' untranslated region encoded in exon 6 is relatively large (2.1 kb) (Fig I) . We sequenced parts of the introns that flank exons (Fig 2) .
To determine the 5'-end of exon 1, we analyzed the transcription start site using RNA from peripheral blood polymorphonuclear leukocytes. By the 5' RACE method, a major band and a 100-bp shorter minor band were obtained (Fig  3) . The major band was cloned and 13 clones were sequenced. The 5"termini of 10 clones corresponded to the 5'-end of the previously cloned PIG-A cDNA, indicating that this is a major transcriptional site and that exon 1 contains 23 bp. The other three clones started from position 11, indicating that this is a second minor start site. Table l For sequences of the exon-intron boundaries. All splice donor and acceptor sites had typical sequences.
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Analysis of the Y-Jlanking region of the PIG-A gene. Clone 2 contained 583 bp upstream of exon I (Fig 2) . There is no TATA-like sequence in this region, but there are four CAAT boxes (-53 to -57, -97 to -101, -292 to -296, and -473 to -477), two AP-2 sequences (-72 to -79 and -147 to -154). and a CRE sequence (-169 to -176) (Figs   2 and 4) .
We assessed the activity of this region as a promoter. Various portions of this region placed upstream of a reporter luciferase gene were assessed for promoter activity by transfection into a B-lymphoblastoid cell line and measurement of induced luciferase activity (Fig 4) . Deletion of 185 bp including the most upstream CAAT box (construct C) caused 50% loss of the activity (Fig 4) . Further deletion of 166 bp, which includes the second CAAT box (constructs D and E) had no effect, but deletion of another 125 bp which contains the CRE and one of the AP-2 sequences (construct F) caused 50% loss of activity. Further deletion of the sequence of 43 bp, which contains the third CAAT box and the other AP-2 sequence (construct G), resulted in almost complete loss 1 2 3 of the activity (Fig 4B) . So the CAAT boxes at -97 to -101 and -473 to -477, the CRE sequence, and the AP-2 sequence at -72 to -79 are possibly important for expression of the PIG-A gene.
Design of primers for PCR amplijication of various regions of the PIG-A gene. We recently analyzed PIG-A transcripts in neutrophils from 15 patients with PNH." In some patients somatic mutations were shown within the coding region by analysis of the transcripts. But other patients had splicing abnormalities or lacked the transcript, so analysis of DNA is necessary for those patients. Based on the nucleotide sequences determined in this study (Fig 2) and the previously determined sequences of PIG-A cDNA," we designed pairs of oligonucleotide primers for PCR amplification of various regions of the PIG-A gene ( Table 2 ). These 13 regions include all exon-intron boundaries, entire exons, and 583 bp of the 5"flanking region (Fig 1) . Using these pairs of primers, the respective reaction conditions shown in Table 2 and DNA template prepared from peripheral blood leukocytes from normal individuals, these DNA regions were efficiently amplified by PCR (data not shown). Because most of the PCR products are 300 to 400 bp in size, they are suitable for 
